Semaglutide in CKD - The Flow Trial NEJM 2024 (Journal Club Idol)

[@ahmednabil616]

Fantastic as usual

[@abhishekmj91]

Is it just semaglutide or is it a class effect, tirezepatide leads to more weight loss 15% vs 12%, can we substitute mounjaro for ozempic. Also the other question comes in regards to the funding. I strongly doubt Medicare is gonna pay for a weight loss drug in a non T2DM setting (seeing they refused to publicly fund wegovy/zepbound)